Any cataract in which the cause of the disease is a mutation in the FYCO1 gene.
Comprehensive, easy-to-understand information about this condition
How we create this content →Documentation for cataract 18 is limited due to its rarity and the recent identification of its genetic basis. Conditions like cataract 18 affect a small number of individuals, making systematic clinical studies challenging. Additionally, the lack of well-defined clinical features complicates the understanding of this condition. Ongoing research may help to clarify these aspects in the future.
To navigate your journey with cataract 18, consider consulting with a geneticist or an ophthalmologist who specializes in hereditary eye disorders. These specialists can provide insights into genetic testing and management options. Additionally, while there are currently no identified patient organizations, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer valuable information. Genetic counseling may also be beneficial for understanding the implications of the FYCO1 mutation and discussing family planning options.
Currently, there is one active clinical trial related to cataract 18. You can find more details about this trial and its eligibility criteria by visiting https://clinicaltrials.gov/search?cond=cataract%2018. While there are no orphan drugs designated for this condition, participation in clinical trials may provide access to new treatment options and contribute to advancing knowledge about cataract 18.
Actionable guidance for navigating care for cataract 18
To navigate your journey with cataract 18, consider consulting with a geneticist or an ophthalmologist who specializes in hereditary eye disorders. These specialists can provide insights into genetic testing and management options. Additionally, while there are currently no identified patient organizations, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer valuable information. Genetic counseling may also be beneficial for understanding the implications of the FYCO1 mutation and discussing family planning options.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Documentation for cataract 18 is limited due to its rarity and the recent identification of its genetic basis. Conditions like cataract 18 affect a small number of individuals, making systematic clinical studies challenging. Additionally, the lack of well-defined clinical features complicates the understanding of this condition. Ongoing research may help to clarify these aspects in the future.
To navigate your journey with cataract 18, consider consulting with a geneticist or an ophthalmologist who specializes in hereditary eye disorders. These specialists can provide insights into genetic testing and management options. Additionally, while there are currently no identified patient organizations, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer valuable information. Genetic counseling may also be beneficial for understanding the implications of the FYCO1 mutation and discussing family planning options.
Currently, there is one active clinical trial related to cataract 18. You can find more details about this trial and its eligibility criteria by visiting https://clinicaltrials.gov/search?cond=cataract%2018. While there are no orphan drugs designated for this condition, participation in clinical trials may provide access to new treatment options and contribute to advancing knowledge about cataract 18.
Actionable guidance for navigating care for cataract 18
To navigate your journey with cataract 18, consider consulting with a geneticist or an ophthalmologist who specializes in hereditary eye disorders. These specialists can provide insights into genetic testing and management options. Additionally, while there are currently no identified patient organizations, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer valuable information. Genetic counseling may also be beneficial for understanding the implications of the FYCO1 mutation and discussing family planning options.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Documentation for cataract 18 is limited due to its rarity and the recent identification of its genetic basis. Conditions like cataract 18 affect a small number of individuals, making systematic clinical studies challenging. Additionally, the lack of well-defined clinical features complicates the understanding of this condition. Ongoing research may help to clarify these aspects in the future.
To navigate your journey with cataract 18, consider consulting with a geneticist or an ophthalmologist who specializes in hereditary eye disorders. These specialists can provide insights into genetic testing and management options. Additionally, while there are currently no identified patient organizations, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer valuable information. Genetic counseling may also be beneficial for understanding the implications of the FYCO1 mutation and discussing family planning options.
Currently, there is one active clinical trial related to cataract 18. You can find more details about this trial and its eligibility criteria by visiting https://clinicaltrials.gov/search?cond=cataract%2018. While there are no orphan drugs designated for this condition, participation in clinical trials may provide access to new treatment options and contribute to advancing knowledge about cataract 18.
Actionable guidance for navigating care for cataract 18
To navigate your journey with cataract 18, consider consulting with a geneticist or an ophthalmologist who specializes in hereditary eye disorders. These specialists can provide insights into genetic testing and management options. Additionally, while there are currently no identified patient organizations, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer valuable information. Genetic counseling may also be beneficial for understanding the implications of the FYCO1 mutation and discussing family planning options.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.